跳至主要内容
临床试验/NCT06155734
NCT06155734招募中不适用

Fluorescence Guided Minimally-Invasive Resection Of Abdominal Paragangliomas Using Indocyanine Green

Leiden University Medical Center1 个研究点 分布在 1 个国家目标入组 6 人开始时间: 2023年11月11日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
6
试验地点
1
主要终点
Feasibility of real-time in-vivo identification of suspected paraganglioma's using Near-Infrared-fluorescence ICG imaging

研究概览

简要总结

This study is exploring whether it's possible to detect paragangliomas (a rare type of tumor) during minimally invasive surgery by using a technique called near-infrared fluorescence imaging, guided by a substance called indocyanine green (ICG). The goal is to see if this method can help surgeons identify and treat paragangliomas more accurately and during minimally invasive procedures.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosed with abdominal paraganglioma and underwent minimally-invasive surgical resection

排除标准

  • Open surgical procedures

研究组 & 干预措施

Retrospective intervention cohort

干预措施: Fluorescence guided identification using indocyanine green (Drug)

结局指标

主要结局

Feasibility of real-time in-vivo identification of suspected paraganglioma's using Near-Infrared-fluorescence ICG imaging

时间窗: perioperatively/periprocedurally, within 30 minutes after intravenous administration of the fluorescent dye, up until a maximum of 120 minutes after start of surgery.

The primary outcome of this retrospective study is the ability to visually detect the proportion (%) of suspected pre-operatively identified lesions (paraganglioma) in the abdomen during minimally invasive procedures using Near-Infrared-fluorescence ICG imaging

次要结局

  • Accuracy of the detection of suspected lesions using Near-Infrared-fluorescence ICG imaging(Postoperatively, at the moment the definitive pathology result is known, approximately five days after surgery)

研究者

发起方
Leiden University Medical Center
申办方类型
Other
责任方
Principal Investigator
主要研究者

Alexander Vahrmeijer

Principle investigator, oncologic surgeon, MD, PhD

Leiden University Medical Center

研究点 (1)

Loading locations...

相似试验